Knife or no knife? new trial tests surgery for wrist lumps
NCT ID NCT07162415
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways to treat painful wrist ganglions (fluid-filled lumps). Half of the 220 adult participants will have surgery to remove the ganglion, while the other half will do exercises and use their hand normally. Researchers will measure pain, function, and satisfaction over 6 to 12 months to see which approach works better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- surgery (open or arthroscopic resection)
- What this could lead to
- If surgery proves better than exercises, it could become the preferred treatment for painful wrist ganglions.
- What could go wrong
- This is a relatively small trial (220 people) and results may not apply to everyone. Surgery also carries risks like infection or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 220 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Dec 2035
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * wrist pain located in the ganglion area * diagnosis of ganglion of the wrist, based on clinical examination or imaging findings * age over 18 years * ability to fill out the Finnish or English version of the questionnaires Exclusion Criteria: * pregnant or breast feeding * other known wrist pathology that likely explains the pain * previous surgical treatments of the wrist * wrist ganglion presumed to be related to a work injury
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Connective tissue disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Helsinki University Hospital
NOT_YET_RECRUITINGHelsinki, 00029, Finland
-
Hospital Nova of Central Finland
NOT_YET_RECRUITINGJyväskylä, 40620, Finland
-
National University Hospital
NOT_YET_RECRUITINGSingapore, 119228, Singapore
-
Tampere University Hospital
RECRUITINGTampere, 33521, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive heart biobank launches to unlock secrets of adult heart disease
- New blood tests could help monitor Flare-Ups in kids with arthritis
- Tiny wrist cyst surgery study ends early with only 3 patients
- Shingles vaccine put to the test in frail patients
- New gel could help heal wounds in rare skin disease
- Can flu shots protect autoimmune patients?